oxybutynin has been researched along with n-methylscopolamine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barocelli, E; Bertoni, S; Bonifazi, A; Camalli, M; Campi, G; Del Bello, F; Giannella, M; Matucci, R; Nesi, M; Piergentili, A; Pigini, M; Quaglia, W | 1 |
| Kawashima, A; Oki, T; Uchida, M; Yamada, S | 1 |
| Oki, T; Toma-Okura, A; Yamada, S | 1 |
| Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Okutsu, H; Saitoh, C; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yuyama, H | 1 |
| Fujino Oki, T; Kato, Y; Kurosawa, S; Nanri, M; Uchida, S; Yamada, S; Yoshida, K | 1 |
| Fujino, T; Kageyama, A; Nozawa, Y; Yamada, S; Yoshida, A | 1 |
| Fukata, A; Ito, Y; Nakamura, M; Ogoda, M; Seki, M; Yamada, S | 1 |
7 other study(ies) available for oxybutynin and n-methylscopolamine
| Article | Year |
|---|---|
1,4-dioxane, a suitable scaffold for the development of novel M₃ muscarinic receptor antagonists.
Topics: Animals; Blood Pressure; CHO Cells; Cricetinae; Cricetulus; Crystallography, X-Ray; Dioxanes; Guinea Pigs; Heart Rate; Humans; Molecular Structure; Muscle Contraction; Muscle, Smooth; Rats; Receptor, Muscarinic M3; Stereoisomerism; Structure-Activity Relationship; Urinary Bladder; Urination | 2012 |
In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
Topics: Analysis of Variance; Animals; Cholinergic Antagonists; Colon; Dose-Response Relationship, Drug; Injections, Intravenous; Male; Mandelic Acids; Muscarinic Antagonists; Myocardium; N-Methylscopolamine; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Saliva; Submandibular Gland; Time Factors; Urinary Bladder | 2005 |
Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Male; Mandelic Acids; N-Methylscopolamine; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Saliva; Urinary Bladder Diseases | 2006 |
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Benzofurans; Binding, Competitive; Carbachol; CHO Cells; Cholinergic Agonists; Cresols; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Transfection; Urinary Bladder; Urinary Bladder, Overactive; Urination | 2007 |
Binding activities by propiverine and its N-oxide metabolites of L-type calcium channel antagonist receptors in the rat bladder and brain.
Topics: Analysis of Variance; Animals; Benzilates; Brain; Calcium Channels, L-Type; Diltiazem; Isradipine; Male; Mandelic Acids; N-Methylscopolamine; Protein Binding; Rats; Rats, Sprague-Dawley; Tritium; Urinary Bladder; Verapamil | 2007 |
Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis.
Topics: Adenosine Triphosphate; Animals; Benzhydryl Compounds; Benzofurans; Cresols; Cystitis; Disease Models, Animal; Down-Regulation; Female; Hydrochloric Acid; Mandelic Acids; N-Methylscopolamine; Organophosphonates; Phenols; Phenylpropanolamine; Pirenzepine; Polycyclic Compounds; Pyridoxal Phosphate; Pyrrolidines; Quinuclidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Receptors, Purinergic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urination; Urodynamics | 2010 |
Selective binding of bladder muscarinic receptors in relation to the pharmacokinetics of a novel antimuscarinic agent, imidafenacin, to treat overactive bladder.
Topics: Animals; Imidazoles; Male; Mandelic Acids; Muscarinic Antagonists; N-Methylscopolamine; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Urinary Bladder; Urinary Bladder, Overactive | 2011 |